China Jushi FY2011: Products and glass-fiber technology

The company describes introducing Vipro in FY2011 as an alkali-free glass fiber with high strength and high modulus. Modulus concerns stiffness; the report claims higher strength and modulus than its earlier E6 glass fiber but supplies no numerical specification or comparative test conditions in these passages. The stated customer uses are large wind-turbine blades, pressure vessels and pultruded components. These are intended reinforcement applications, not named customer contracts or product-specific sales. The innovation section also identifies pressure-vessel pipes and suitability for large tank-furnace production. This connects product development to the existing glass-fiber manufacturing platform, without establishing a new dedicated production line or incremental capacity. Management presents Vipro as a new technology platform for further product development. Its expected performance and cost-to-performance advantages remain issuer claims rather than independently verified comparisons with every competing material. E6 and Vipro remain identifiable product families; a disclosure of a higher-performance formulation is distinct from proof that every grade has completed qualification or reached a particular annual sales volume.

The report describes developing Compofil by combining continuous glass fiber and chemical fiber through a special process. It says this combined material can be used directly to produce continuous-fiber-reinforced thermoplastic resin composites without adding separate resin. This is the disclosed distinction from supplying a glass-fiber reinforcement alone; the passage does not identify the chemical fiber, resin chemistry or blend proportions. Management associates the product with simpler forming, higher production efficiency and recyclability, and claims improved composite performance without supplying comparative measurements. Its listed application areas include defense, aerospace, new energy, automobiles, construction and sporting equipment. These describe potential uses of the material and must not be read as deliveries to named customers in every sector. The FY2011 passage describes development and intended use; it does not expressly establish the later stable batch-production milestone, customer-specific qualification, annual output or product revenue. The material's constituents, use in thermoplastic-composite forming and disclosed development stage therefore remain separate from claims about realized commercial scale.

The quality discussion lists new ship-classification product certifications recorded as GL, LR and DNV: three, six and five respectively during FY2011. The source identifies these bodies in its preceding paragraph but has inconsistent Chinese wording for GL in the new-certification list; the acronym and reported count are preserved without inventing a different organization. The same list reports four tests labeled FDA, eight labeled RoHS and seven labeled REACH. These are disclosed test counts, not a demonstrated blanket approval for every product or every export market. The company also obtained a company code in the International Material Data System, or IMDS, which the report describes as access to an automotive-industry parts-and-materials database developed jointly by automobile manufacturers. A registration code enables the disclosed database access; it does not establish a supply order from those manufacturers. The report separately describes quality, environmental, occupational-health and measurement management-system certifications. System certification, individual product certification, testing and database registration remain distinct kinds of qualification evidence, without inferred customer volumes or independent confirmation that all requirements for an intended use were met.

Reported product certifications / 2011 / gl new fy2011

3 certifications

Reported product certifications / 2011 / lr new fy2011

6 certifications

Reported product certifications / 2011 / dnv new fy2011

5 certifications

Reported product tests / 2011 / fda new fy2011

4 tests

Reported product tests / 2011 / rohs new fy2011

8 tests

Reported product tests / 2011 / reach new fy2011

7 tests

Management describes research infrastructure including a postdoctoral research station, an accredited testing center, a provincial glass-fiber research laboratory and the Jushi glass-fiber research institute. The innovation discussion describes additional institutional construction and speaks prospectively about the laboratory's position when completed. It does not establish an independently assessed global ranking or a precise completion date for every facility. In the financial notes, FY2011 technical-development expense within administrative expenses was CNY 157,596,685.59. The cash-flow note separately reports CNY 66,584,331.21 paid for research and development. Expense recognition and a disclosed cash-payment line are different measures and must not be added as two separate research programmes or substituted for one another. They indicate resources committed to development alongside the product descriptions, but do not provide project-by-project allocations, a fully reconciled expense-to-cash bridge or proof that all spending produced commercial products. The passage does not support converting every technical employee into an R&D headcount.

Reported technical development expense / 2011 / consolidated administrative expense fy2011

RMB 157,596,685.59

Reported research cash payments / 2011 / consolidated annual fy2011

RMB 66,584,331.21

The FY2011 innovation discussion reports 47 patent applications, comprising 22 invention applications and 25 utility-model applications. It separately reports 68 authorizations during the year, comprising eight invention patents and 60 utility-model patents. Grants in a year can relate to applications from a different cohort; the difference between applications and authorizations is not itself an inconsistency or a conversion rate. The report also states an accumulated 164 authorized patents, comprising 21 invention and 143 utility-model patents, using an 'at present' time description rather than expressly assigning that stock to 31 December 2011. The cumulative figure is retained with that time boundary and is not recorded as a precise year-end stock. These measures describe intellectual-property activity associated with the manufacturing and product-development platform. They do not count distinct commercial products or show revenue, customer adoption or independently proven superiority. Awards and project-application counts are not substituted for patent rights or operating results.

Reported patent applications / 2011 / innovation fy2011

47 applications

Reported invention patent applications / 2011 / innovation fy2011

22 applications

Reported utility patent applications / 2011 / innovation fy2011

25 applications

Reported patent authorizations / 2011 / innovation fy2011

68 patents

Reported invention patent authorizations / 2011 / innovation fy2011

8 patents

Reported utility patent authorizations / 2011 / innovation fy2011

60 patents